MT1JP and central nervous system cancer: it is downregulated in patient tissues and cell lineslower expression is associated with glioma progression and poor patient survivaloverexpression of MT1JP reduces the proliferation and invasionMT1JP interacts with miR-24 and negatively regulates its expression level and influences cellular phenotype